Establishing a European Medicine Supply Chain Research Network
The MIA project hosted a two-day hybrid event, 15 to 16 May held at BI Norwegian Business School – campus Oslo.
News
The Measures for Improved Availability of Medicines and Vaccines (MIA) project brought together European medicine supply chain actors, medicine regulators and researchers to disseminate key project insights, engage in ongoing research and to take steps towards the establishment of a European Medicine Supply Chain Research Network, during a two-day hybrid event, 15 to 16 May held at BI Norwegian Business School – campus Oslo.
Presentations from the event and the recordings from the hybrid sessions are provided below.
Day one – Stakeholders and Policy Makers
MIA researchers and The Norwegian Hospital Procurement Trust presented key research and tools to improve medicine availability, to international researchers and stakeholders including the Norwegian Medical Products Agency, Norwegian Pharmacy Association, Farma Norge, Association of the Pharmaceutical Industry in Norway, Norwegian Directorate of Health, National Centre for Medicine Shortages and Medicine Preparedness in Specialist Health Services and Norsk Medisinaldepot AS, and representatives from the UK and the Netherlands, who joined us online.
Day two – Researchers
Norwegian, EU, UK, US, and Ethiopian researchers shared relevant ongoing and potential research. We agreed to collaborate further and take steps to advance a European Medicine Supply Chain Research Network to develop resilient, sustainable supply chains and provide evidence-based support to decision-makers.
Recordings
Session 1 and 2
Session 4
Presentations from the sessions
-
-
- How the UK health system responded to supply chain issues during Brexit & the COVID-19 pandemic: From risk-responding to opportunity exploitation (Nonhlanhla Dube, Lancaster University)
- Optimizing Minimum Stock Obligations for Medicines (Harwin de Vries, Erasmus University)
- Use of most economically advantageous tender (MEAT) criteria to improve security of supply (Eirik Sverrisson, Norwegian Hospital Procurement Trust)
-
- Medicines shortages in the UK - a synopsis of ongoing projects and activity (Liz Breen, University of Bradford)
- Evaluating Drug Shortage Propagation Across Countries (Emilia Vann Yaroson, University of Huddersfield)
- Assessment of Primary Care Service Operational Resilience by Patients: Implications for COVID-19 Recovery (Ying Xie, Cranfield School of Management)
- Platinea - policy options to address antibiotic shortages (Sofia Wagrell, Uppsala University)
- Envisioning an Improved Information Infrastructure for Drug Shortage Prevention and Mitigation: Research at the Intersection of Behavioral Modeling, Complex Systems Modeling, and Data Analytics (Jacqueline Griffin, Northeastern University)
-
- Prescriptions in Peril: Unravelling the Web of Shortages in Low-Resource Settings (Zeleke Mekonnen, Jimma University)
- Global Finished Generic Drug Manufacturing: Studies on Quality, Monitoring, and Opacity (John Gray, The Ohio State University)
- Improving Information Infrastructure for Better Decision Making in Pharmaceutical Supply Chains (Jacqueline Griffin, Northeastern University)
